Skip to content Skip to menu

In partnership with key stakeholders, Medicines Australia drives the creation and development of an environment for the continued sustainable growth of the innovative research based prescription medicines industry

About Us

Papers, Reports & Submissions

Publications

Agreements, Indemnity & Compensation Guidelines

Clinical Trials

Awards, Speeches & Media Releases

Media & Events

Member company lounge

Member's Area

Sign up for updates

Sign up for email updates to keep on top of Medicines Australia developments.


Social

Transparency builds confidence in the fantastic work the medicines industry is doing: MA Chief Exec Milton Catelin. https://t.co/C8KReIlvEP

RT @PharmaInFocusAu: @MedicinesAus & @CHFofAustralia criticise accuracy of media report on Aus pharma's transparency with patient groups ht…

RT @KenWyattMP: Deeply honoured to be appointed Minister for Aged Care, and Minister for Indig Health. Thank you all for the kind words of…

Medicines Australia welcomes new appointments to Health and Industry portfolios https://t.co/qkObKW1Vga

Seeking: Thought Leaders: New Advisory Council to Medicines Australia https://t.co/6H89xPuZwg

Seeking: Thought Leaders: New Advisory Council to Medicines Australia https://t.co/CpYkuo3Mah https://t.co/dC8XucMZAY

Good article in the New England Journal of Medicine today on possible revisions to Obamacare under Trump Admin. https://t.co/gDZZYSkH98

Productivity Commission’s Report Recommendations Would Hurt Australian Innovation and Delay Access to… https://t.co/paxe5Fp6Ch

New member appointees to the Medicines Australia Board https://t.co/YvxKsPUIGi

Former AusBiotech CEO appointed to Medicines Australia Board as Independent Director https://t.co/lDvozwCdY7

Medicines Australia Member To Play A Crucial Role In The Biomedical Translation Fund https://t.co/YWn58BoS9S

Legislation will improve access to medicines and cut red-tape https://t.co/9x8GZ3wSa0

See how Monash University and MA members are working together on biopharmaceutical innovation. https://t.co/6K5ZTXWJOJ via @FinancialReview

Top